Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in quality of life and sexual health are associated with low-dose peginterferon therapy and disease progression in patients with chronic hepatitis C.
Snow KK, Bonkovsky HL, Fontana RJ, Kim HY, Sterling RK, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG; HALT-C Trial Group. Snow KK, et al. Among authors: di bisceglie am. Aliment Pharmacol Ther. 2010 Apr;31(7):719-34. doi: 10.1111/j.1365-2036.2010.04235.x. Epub 2010 Jan 12. Aliment Pharmacol Ther. 2010. PMID: 20070284 Free PMC article. Clinical Trial.
Antigen-specific T lymphocyte proliferation decreases over time in advanced chronic hepatitis C.
Morishima C, Di Bisceglie AM, Rothman AL, Bonkovsky HL, Lindsay KL, Lee WM, Koziel MJ, Fontana RJ, Kim HY, Wright EC; HALT-C Trial Group. Morishima C, et al. Among authors: di bisceglie am. J Viral Hepat. 2012 Jun;19(6):404-13. doi: 10.1111/j.1365-2893.2011.01562.x. Epub 2011 Dec 16. J Viral Hepat. 2012. PMID: 22571902 Free PMC article. Clinical Trial.
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevir.
Sterling RK, Kuo A, Rustgi VK, Sulkowski MS, Stewart TG, Fenkel JM, El-Genaidi H, Mah'moud MA, Abraham GM, Stewart PW, Akushevich L, Nelson DR, Fried MW, Di Bisceglie AM. Sterling RK, et al. Among authors: di bisceglie am. Aliment Pharmacol Ther. 2015 Apr;41(7):671-85. doi: 10.1111/apt.13095. Epub 2015 Jan 28. Aliment Pharmacol Ther. 2015. PMID: 25627020 Free PMC article. Clinical Trial.
Psychometric properties of the PROMIS short form measures in a U.S. cohort of 961 patients with chronic hepatitis C prescribed direct acting antiviral therapy.
Evon DM, Amador J, Stewart P, Reeve BB, Lok AS, Sterling RK, Di Bisceglie AM, Reau N, Serper M, Sarkar S, Lim JK, Golin CE, Fried MW. Evon DM, et al. Among authors: di bisceglie am. Aliment Pharmacol Ther. 2018 Apr;47(7):1001-1011. doi: 10.1111/apt.14531. Epub 2018 Jan 29. Aliment Pharmacol Ther. 2018. PMID: 29377191 Free PMC article.
Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
Di Bisceglie AM, Bonkovsky HL, Chopra S, Flamm S, Reddy RK, Grace N, Killenberg P, Hunt C, Tamburro C, Tavill AS, Ferguson R, Krawitt E, Banner B, Bacon BR. Di Bisceglie AM, et al. Hepatology. 2000 Jul;32(1):135-8. doi: 10.1053/jhep.2000.8700. Hepatology. 2000. PMID: 10869301 Clinical Trial.
All-oral direct-acting antiviral therapy in HCV-advanced liver disease is effective in real-world practice: observations through HCV-TARGET database.
Reddy KR, Lim JK, Kuo A, Di Bisceglie AM, Galati JS, Morelli G, Everson GT, Kwo PY, Brown RS Jr, Sulkowski MS, Akuschevich L, Lok AS, Pockros PJ, Vainorius M, Terrault NA, Nelson DR, Fried MW, Manns MP; HCV-TARGET Study Group. Reddy KR, et al. Among authors: di bisceglie am. Aliment Pharmacol Ther. 2017 Jan;45(1):115-126. doi: 10.1111/apt.13823. Epub 2016 Oct 28. Aliment Pharmacol Ther. 2017. PMID: 27790729
Treatment of chronic type B hepatitis.
Di Bisceglie AM, Hoofnagle JH. Di Bisceglie AM, et al. Cancer Detect Prev. 1989;14(2):291-3. Cancer Detect Prev. 1989. PMID: 2620310
Prolonged therapy of chronic hepatitis C with ribavirin.
Hoofnagle JH, Lau D, Conjeevaram H, Kleiner D, Di Bisceglie AM. Hoofnagle JH, et al. Among authors: di bisceglie am. J Viral Hepat. 1996 Sep;3(5):247-52. doi: 10.1111/j.1365-2893.1996.tb00050.x. J Viral Hepat. 1996. PMID: 8914004 Clinical Trial.
Management of chronic viral hepatitis in children.
Conjeevaram HS, Di Bisceglie AM. Conjeevaram HS, et al. Among authors: di bisceglie am. J Pediatr Gastroenterol Nutr. 1995 May;20(4):365-75. doi: 10.1097/00005176-199505000-00001. J Pediatr Gastroenterol Nutr. 1995. PMID: 7636678 Review.
404 results